BPC-157 | Research Grade Peptide
US$ 26.18
50mg ghk-cu GHK CU COPPER 50mg –
Description
For researchers, this consolidation creates a paradoxically better environment: the average quality of available suppliers has increased, because the market-clearing event removed the least compliant, least transparent, and most risk-prone operators
Treatment starts at 0.25 mg weekly and increases every four weeks through 0.5 mg, 1.0 mg, and 1.7 mg before reaching the maintenance dose of 2.4 mg per week
They share GLP-1 receptor activity
If you are following a microdosing tirzepatide protocol , the 2ml reconstitution gives you much more precise measurements
